Genomics

Dataset Information

0

First-in-class microbial ecosystem therapeutics 4 (MET4) in combination with immune checkpoint inhibitors in patients with advanced solid tumours (MET4-IO Trial)


ABSTRACT: The intestinal microbiome has been associated with response to immune checkpoint inhibitors (ICI) in humans, and causally implicated in ICI responsiveness in animal models. Therapeutic augmentation of the microbiome in ICI recipients is being investigated in multiple ongoing human clinical trials. We conducted an early phase clinical trial of a cultivated, orally-delivered 30-species microbial consortium (microbial ecosystem therapeutic-4, MET4) designed for co-administration with ICIs and assessed safety, tolerability and ecological responses in patients with advanced solid tumors.

ORGANISM(S): human feces metagenome

PROVIDER: GSE199245 | GEO | 2022/03/26

REPOSITORIES: GEO

Similar Datasets

2019-08-29 | PXD010060 | Pride
2019-08-29 | PXD010185 | Pride
2015-04-03 | E-GEOD-67531 | biostudies-arrayexpress
| PRJNA819052 | ENA
2015-04-03 | GSE67531 | GEO
2020-11-01 | E-MTAB-8867 | biostudies-arrayexpress
2020-12-14 | PXD023099 | iProX
2023-03-17 | GSE227404 | GEO
2022-11-16 | GSE218139 | GEO
2022-11-14 | GSE217917 | GEO